Skip to main content

CRO%20BIOBANK

Page 1

CENTRO DI RIFERIMENTO ONCOLOGICO

Technology Transfer Opportunities Contact: Ermes Mestroni emestroni@cro.it

CRO BIOBANK Technology Overview CRO-BIOBANK is a large collection of human biological samples and associated information collected in diagnosis and consecutive therapeutical stages for research purposes. Samples, including serum, plasma (EDTA or citrate), buffy-coat, tissue and DNA of healthy individuals and patients (cancer and/or other related pathologies), are collected and stored in compliance with Quality standards. Pharmaceutical industry has new and innovative molecular targets and resources for prevention and personalization of medical treatment.

Advantages √ Long-term source of DNA for genetic studies and

√ √ √ √

materials for biochemical, immunological, and proteomics analysis; Homogeneous and stable samples (standardized collection, process, and storage methods, Quality system); Centralized collections; Statistically significant number of available samples; Standard procedures for samples exchange (MTA).


CENTRO DI RIFERIMENTO ONCOLOGICO

Technology Transfer Opportunities Contact: Ermes Mestroni emestroni@cro.it

Development Stage

> 100 m 2

Access: fingerprint identification

Looking for Collaborations with industrial partners aimed to: ⇒ Identify new pharmacological targets, ⇒ Study the efficacy of new therapies and vaccines, ⇒ Produce diagnostic kits (eg. identification of new biomarkers), ⇒ Test the efficacy of new kits, compare them to existing ones, validate, ⇒ Study preservation methods for biological materials, ⇒ Identify gene mutations / biomarkers predisposing neoplasias, ⇒ Validate diagnostic tests for procreative associated risks.

More Information Silvia Cervo Project Manager scervo@cro.it +39-0434-659-711

Agostino Steffan, MD Division of Oncological Pathology asteffan@cro.it +39-0434-659-188


Turn static files into dynamic content formats.

Create a flipbook
CRO%20BIOBANK by CRO - Aviano - Issuu